(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-06 View latest technical analysis
10 day averaged volume of Ascendis Pharma is 243081
Date | Daily Closing Price | Open | High | Low | Volume |
06 Tue Aug 2024 | 125.51 | 126.09 | 129.34 | 124.79 | 0.655 times |
05 Mon Aug 2024 | 124.99 | 121.12 | 127.92 | 120.18 | 1.402 times |
02 Fri Aug 2024 | 132.26 | 135.70 | 135.70 | 127.93 | 1.295 times |
01 Thu Aug 2024 | 136.53 | 133.56 | 137.36 | 132.17 | 1.043 times |
31 Wed Jul 2024 | 133.50 | 134.11 | 138.15 | 132.22 | 1.244 times |
30 Tue Jul 2024 | 133.94 | 134.16 | 134.30 | 130.57 | 1.258 times |
29 Mon Jul 2024 | 134.25 | 133.75 | 135.55 | 132.56 | 0.639 times |
26 Fri Jul 2024 | 133.75 | 135.48 | 136.36 | 132.99 | 0.723 times |
25 Thu Jul 2024 | 134.38 | 133.97 | 136.41 | 133.91 | 0.731 times |
24 Wed Jul 2024 | 134.01 | 134.35 | 135.50 | 132.46 | 0.743 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 126.5, for a target of 131 or 134.67
Share price targets for Ascendis Pharma (ASND)
Target Type | Value |
Downside Target | 116.63 |
Downside Target | 120.18 |
Upside Target | 127.93 |
Upside Target | 137.62 |
Upside Target | 138.15 |
Upside Target | 140.09 |
Upside Target | 140.87 |
Upside Target | 142.21 |
Upside Target | 143.99 |
Upside Target | 156.84 |
Intraday share price targets for Ascendis Pharma (ASND)
Target Type | Value |
Downside Intraday Target | 120.68 |
Downside Intraday Target | 115.85 |
Upside Intraday Target | 129.84 |
Upside Intraday Target | 134.17 |
Downside Intraday Target | 125.01 |
Weekly technical analysis of Ascendis Pharma (ASND)
Date | Weekly Closing Price | Open | High | Low | Volume |
06 Tue Aug 2024 | 125.51 | 121.12 | 129.34 | 120.18 | 0.376 times |
02 Fri Aug 2024 | 132.26 | 133.75 | 138.15 | 127.93 | 1.278 times |
26 Fri Jul 2024 | 133.75 | 135.67 | 137.62 | 132.46 | 0.606 times |
19 Fri Jul 2024 | 135.21 | 138.91 | 142.21 | 132.59 | 1.122 times |
12 Fri Jul 2024 | 138.08 | 136.29 | 140.87 | 134.74 | 6.012 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
Date | Monthly Closing Price | Open | High | Low | Volume |
06 Tue Aug 2024 | 125.51 | 133.56 | 137.36 | 120.18 | 0.18 times |
31 Wed Jul 2024 | 133.50 | 135.68 | 142.21 | 130.57 | 1.008 times |
28 Fri Jun 2024 | 136.38 | 135.44 | 140.09 | 121.07 | 0.517 times |
31 Fri May 2024 | 135.10 | 137.81 | 143.99 | 116.63 | 1.736 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Ascendis Pharma in short term and the sell signal is strong.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 132.13 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Ascendis Pharma in short term and the sell signal is strong.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 132.13 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.